S&P 500   3,929.23 (-3.90%)
DOW   31,545.65 (-3.40%)
QQQ   292.61 (-4.43%)
AAPL   141.27 (-5.34%)
MSFT   255.80 (-4.13%)
FB   194.22 (-4.15%)
GOOGL   2,259.15 (-3.02%)
AMZN   2,159.00 (-6.43%)
TSLA   707.13 (-7.15%)
NVDA   170.51 (-6.19%)
BABA   87.86 (-4.49%)
NIO   15.86 (-4.63%)
AMD   97.11 (-5.23%)
CGC   5.65 (-4.07%)
MU   71.36 (-4.19%)
T   20.33 (-1.17%)
GE   75.17 (-1.61%)
F   12.84 (-5.10%)
DIS   105.05 (-3.30%)
AMC   12.73 (-1.32%)
PFE   50.53 (-1.58%)
PYPL   77.24 (-3.15%)
NFLX   178.48 (-6.34%)
S&P 500   3,929.23 (-3.90%)
DOW   31,545.65 (-3.40%)
QQQ   292.61 (-4.43%)
AAPL   141.27 (-5.34%)
MSFT   255.80 (-4.13%)
FB   194.22 (-4.15%)
GOOGL   2,259.15 (-3.02%)
AMZN   2,159.00 (-6.43%)
TSLA   707.13 (-7.15%)
NVDA   170.51 (-6.19%)
BABA   87.86 (-4.49%)
NIO   15.86 (-4.63%)
AMD   97.11 (-5.23%)
CGC   5.65 (-4.07%)
MU   71.36 (-4.19%)
T   20.33 (-1.17%)
GE   75.17 (-1.61%)
F   12.84 (-5.10%)
DIS   105.05 (-3.30%)
AMC   12.73 (-1.32%)
PFE   50.53 (-1.58%)
PYPL   77.24 (-3.15%)
NFLX   178.48 (-6.34%)
S&P 500   3,929.23 (-3.90%)
DOW   31,545.65 (-3.40%)
QQQ   292.61 (-4.43%)
AAPL   141.27 (-5.34%)
MSFT   255.80 (-4.13%)
FB   194.22 (-4.15%)
GOOGL   2,259.15 (-3.02%)
AMZN   2,159.00 (-6.43%)
TSLA   707.13 (-7.15%)
NVDA   170.51 (-6.19%)
BABA   87.86 (-4.49%)
NIO   15.86 (-4.63%)
AMD   97.11 (-5.23%)
CGC   5.65 (-4.07%)
MU   71.36 (-4.19%)
T   20.33 (-1.17%)
GE   75.17 (-1.61%)
F   12.84 (-5.10%)
DIS   105.05 (-3.30%)
AMC   12.73 (-1.32%)
PFE   50.53 (-1.58%)
PYPL   77.24 (-3.15%)
NFLX   178.48 (-6.34%)
S&P 500   3,929.23 (-3.90%)
DOW   31,545.65 (-3.40%)
QQQ   292.61 (-4.43%)
AAPL   141.27 (-5.34%)
MSFT   255.80 (-4.13%)
FB   194.22 (-4.15%)
GOOGL   2,259.15 (-3.02%)
AMZN   2,159.00 (-6.43%)
TSLA   707.13 (-7.15%)
NVDA   170.51 (-6.19%)
BABA   87.86 (-4.49%)
NIO   15.86 (-4.63%)
AMD   97.11 (-5.23%)
CGC   5.65 (-4.07%)
MU   71.36 (-4.19%)
T   20.33 (-1.17%)
GE   75.17 (-1.61%)
F   12.84 (-5.10%)
DIS   105.05 (-3.30%)
AMC   12.73 (-1.32%)
PFE   50.53 (-1.58%)
PYPL   77.24 (-3.15%)
NFLX   178.48 (-6.34%)
NASDAQ:PATH

UiPath (PATH) Stock Forecast, Price & News

$16.39
-0.67 (-3.93%)
(As of 05/18/2022 02:28 PM ET)
Add
Compare
Today's Range
$16.23
$17.39
50-Day Range
$14.26
$31.40
52-Week Range
$13.66
$90.00
Volume
147,016 shs
Average Volume
7.77 million shs
Market Capitalization
$8.88 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive PATH News and Ratings via Email

Sign-up to receive the latest news and ratings for UiPath and its competitors with MarketBeat's FREE daily newsletter.

UiPath logo

About UiPath

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:PATH
Fax
N/A
Employees
2,863
Year Founded
2005

Sales & Book Value

Annual Sales
$892.25 million
Book Value
$3.55 per share

Profitability

Net Income
$-525.59 million
Pretax Margin
-57.26%

Debt

Price-To-Earnings

Miscellaneous

Free Float
369,270,000
Market Cap
$8.88 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
3/30/2022
Today
5/18/2022
Next Earnings (Confirmed)
6/01/2022
Fiscal Year End
1/31/2023

Social Links


MarketRank

Overall MarketRank

2.42 out of 5 stars

Business Services Sector

86th out of 463 stocks

Prepackaged Software Industry

63rd out of 298 stocks

Analyst Opinion: 4.3Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -













UiPath (NASDAQ:PATH) Frequently Asked Questions

Is UiPath a buy right now?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 2 sell ratings, 5 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" UiPath stock.
View analyst ratings for UiPath
or view top-rated stocks.

When is UiPath's next earnings date?

UiPath is scheduled to release its next quarterly earnings announcement on Wednesday, June 1st 2022.
View our earnings forecast for UiPath
.

How can I listen to UiPath's earnings call?

UiPath will be holding an earnings conference call on Wednesday, June 1st at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415 with passcode "13729270".

How were UiPath's earnings last quarter?

UiPath Inc. (NASDAQ:PATH) posted its earnings results on Wednesday, March, 30th. The healthcare company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.02) by $0.08. The healthcare company earned $289.70 million during the quarter, compared to analyst estimates of $283.25 million. UiPath had a negative net margin of 58.91% and a negative trailing twelve-month return on equity of 21.20%. UiPath's quarterly revenue was up 39.3% compared to the same quarter last year.
View UiPath's earnings history
.

What guidance has UiPath issued on next quarter's earnings?

UiPath issued an update on its FY 2023 earnings guidance on Wednesday, April, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.08 billion-$1.09 billion, compared to the consensus revenue estimate of $1.16 billion.

What price target have analysts set for PATH?

19 brokerages have issued 1 year price objectives for UiPath's stock. Their forecasts range from $23.00 to $64.00. On average, they expect UiPath's share price to reach $41.18 in the next year. This suggests a possible upside of 151.3% from the stock's current price.
View analysts' price targets for UiPath
or view top-rated stocks among Wall Street analysts.

What are Wall Street analysts saying about UiPath stock?
Here are some recent quotes from research analysts about UiPath stock:
  • 1. According to Zacks Investment Research, "UiPath Inc. offers an end-to-end platform for automation, combining Robotic Process Automation solution for digital business operations. UiPath Inc. is based in New York, United States. " (4/7/2022)
  • 2. The analyst says his price target cut reflects his updated discount cash flow model, but he also recommends that investors take advantage of the broad weakness that has impacted software as an attractive buying opportunity to buy UiPath for its long-term compounding growth story. Tillman further points to the company's record net new ARR, "constructive" Q4 outlook, and a variety of new innovations in the pipeline such as automation bots for Mac users, multi-cloud multi-platform capabilities, automation cloud traction, and task/process mining." (12/9/2021)
  • 3. The analyst notes UiPath delivered another "solid" beat across top-line metrics for Q3, including a quarterly record for net new ARR and total revenue growth of +50%. While Q3 was strong, the full-year ARR guide increased by $22M, implying a modest $2M raise post the $20M Q3 beat, Turrin adds. With Q3 results coming in clean, he expects investor conversation will focus in on what's ahead for new business activity into a seasonally strong Q4 and the potential for pent-up automation demand in a tight labor market heading into fiscal 2023. While UiPath continues to blaze a trail toward broad-based RPA adoption, current valuation levels and a rapidly evolving market backdrop leave the analyst more balanced on shares. " (12/9/2021)
Who are UiPath's key executives?
UiPath's management team includes the following people:
  • Mr. Daniel Solomon Dines, Co-Founder, CEO, & Chairman (Age 50, Pay $216.08k)
  • Mr. Ted Kummert, Exec. VP of Products & Engineering (Age 59, Pay $629.82k) (LinkedIn Profile)
  • Mr. Marius Tirca, Co-Founder & CTO
  • Mr. Ashim Gupta, Chief Financial Officer (Age 43) (LinkedIn Profile)
  • Ms. Kelsey Doherty Turcotte, Sr. VP of Investor Relations
  • Mr. Brad C. Brubaker, Gen. Counsel, Chief Legal Officer & Sec. (Age 58) (LinkedIn Profile)
  • Mr. Robert B. Patrick, Chief Marketing Officer (Age 50)
  • Mr. Christopher Townsend, VP of Federal Sales
  • Mr. Vijay Khanna, Chief Corp. Devel. Officer
  • Ms. Bettina H. Koblick, Chief People Officer (Age 56)
What other stocks do shareholders of UiPath own?
When did UiPath IPO?

(PATH) raised $990 million in an IPO on Wednesday, April 21st 2021. The company issued 21,300,000 shares at a price of $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities acted as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers.

What is UiPath's stock symbol?

UiPath trades on the NASDAQ under the ticker symbol "PATH."

Who are UiPath's major shareholders?

UiPath's stock is owned by many different institutional and retail investors. Top institutional shareholders include ARK Investment Management LLC (6.40%), Vanguard Group Inc. (4.57%), Nikko Asset Management Americas Inc. (3.88%), Wellington Management Group LLP (2.82%), Altimeter Capital Management LP (1.53%) and Goldman Sachs Group Inc. (1.34%). Company insiders that own UiPath stock include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Hitesh Ramani, Kimberly Hammonds, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert and Thomas Neergaard Hansen.
View institutional ownership trends for UiPath
.

Which institutional investors are selling UiPath stock?

PATH stock was sold by a variety of institutional investors in the last quarter, including Tiger Global Management LLC, Allianz Asset Management GmbH, Eagle Asset Management Inc., Dragoneer Investment Group LLC, Wellington Management Group LLP, National Bank of Canada FI, LA Financiere DE L Echiquier, and Royal Bank of Canada. Company insiders that have sold UiPath company stock in the last year include Ashim Gupta, Brad Brubaker, Daniel Dines, Hitesh Ramani, Kimberly Hammonds, Philippe Botteri, Rich Wong, Ted Kummert, and Thomas Neergaard Hansen.
View insider buying and selling activity for UiPath
or view top insider-selling stocks.

Which institutional investors are buying UiPath stock?

PATH stock was purchased by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, Altimeter Capital Management LP, Nikko Asset Management Americas Inc., Renaissance Technologies LLC, Vanguard Group Inc., JPMorgan Chase & Co., Blackstone Inc., and American Century Companies Inc..
View insider buying and selling activity for UiPath
or or view top insider-buying stocks.

How do I buy shares of UiPath?

Shares of PATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UiPath's stock price today?

One share of PATH stock can currently be purchased for approximately $16.39.

How much money does UiPath make?

UiPath has a market capitalization of $8.88 billion and generates $892.25 million in revenue each year. The healthcare company earns $-525.59 million in net income (profit) each year or ($1.65) on an earnings per share basis.

How many employees does UiPath have?

UiPath employs 2,863 workers across the globe.

Does UiPath have any subsidiaries?

The following companies are subsidiares of UiPath: Magna View BV, Process Gold International BV, ProcessGold, StepShot, UiPath AB, UiPath Australia Pty Ltd, UiPath Canada, UiPath China - Shanghai, UiPath France SAS, UiPath GMBH, UiPath Hong Kong, UiPath KK, UiPath Limited, UiPath Ltd. (India), UiPath Ltd. (SG), UiPath Ltd. (UK), UiPath Netherlands B.V., UiPath Netherlands Holding B.V., UiPath SRL, UiPath South Korea, and UiPath Switzerland GmbH.

When was UiPath founded?

UiPath was founded in 2005.

What is UiPath's official website?

The official website for UiPath is www.nupathe.com.

How can I contact UiPath?

UiPath's mailing address is 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States. The healthcare company can be reached via phone at 844-432-0455 or via email at [email protected].

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.